- Conditions
- Healthy
- Interventions
- Levoketoconazole, Ketoconazole
- Drug
- Lead sponsor
- Cortendo AB
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Endogenous Cushing's Syndrome
- Interventions
- Levoketoconazole, Placebo
- Drug
- Lead sponsor
- Cortendo AB
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 13
- States / cities
- Los Angeles, California • Fort Lauderdale, Florida • Atlanta, Georgia + 7 more
- Conditions
- Cushing Syndrome, Cushing Disease
- Interventions
- Levoketoconazole
- Drug
- Lead sponsor
- Cortendo AB
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 8
- States / cities
- Fort Lauderdale, Florida • Atlanta, Georgia • St Louis, Missouri + 4 more
- Conditions
- Healthy Subjects
- Interventions
- levoketoconazole
- Drug
- Lead sponsor
- Cortendo AB
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Healthy Subjects
- Interventions
- Metformin 500 mg Oral Tablet, Levoketoconazole 150 - 600 mg (BID)
- Drug
- Lead sponsor
- Cortendo AB
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Endogenous Cushing's Syndrome
- Interventions
- Levoketoconazole
- Drug
- Lead sponsor
- Cortendo AB
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 94 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Baltimore, Maryland • Boston, Massachusetts + 6 more